Cataract surgery using low pressure techniques for glaucoma patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with both glaucoma and cataracts undergoing cataract surgery. It aims to collect data on the safety and efficacy of the Quatera 700 phacoemulsification system, which allows for cataract surgery to be performed at significantly lower intraocular pressures. The study will monitor various parameters before, during, and after the surgical procedure to assess the impact of low pressure on patient outcomes. The innovative device is designed to minimize the risk of additional damage to the optic nerve during surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with glaucoma that are diagnosed with age-related cataract

Exclusion Criteria:

* Unwilling to sign informed consent
* Functionally monophtalmic patient
* Endothelial dystrophy
* Active uveitis
* Known corticosteroid responder
* Presence of uncontrolled systemic disease

Where it's running

• Visionair Oogzorg
  Geel, Belgium Recruiting

Study contacts

• Principal investigator: Koen Willekens — Visionair Oogzorg
• Study coordinator: Koen Willekens, Prof
• Email: kw@visionairoogzorg.be
• Phone: 003214808311

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Measuring eye pressure and fluid outflow during cataract or glaucoma surgery

  This will test whether measuring eye pressure and fluid outflow during cataract or glaucoma surgery with a disposable sensor can help predict and improve recovery for adults having these operations.

  Recruiting The New York Eye & Ear Infirmary · New York, New York · NCT07425496

• Bimatoprost implant with SpyGlass intraocular lens vs timolol drops for cataract patients with glaucoma

  This study tests whether placing a bimatoprost implant together with a SpyGlass intraocular lens during cataract surgery controls eye pressure better than daily timolol drops in people with mild to moderate open‑angle glaucoma or ocular hypertension.

  Recruiting Phase 3 SpyGlass Pharma, Inc. · San Antonio, Texas · NCT07218796

• Combining a bimatoprost eye implant with the SpyGlass intraocular lens versus timolol eye drops for people having cataract removal

  This study will test whether placing a small bimatoprost implant with the SpyGlass intraocular lens at the time of cataract surgery better controls eye pressure than using timolol eye drops in people with mild to moderate open-angle glaucoma or ocular hypertension.

  Recruiting Phase 3 SpyGlass Pharma, Inc. · Houston, Texas · NCT07218783

• My Eyes, My Light — community eye screening in Char Fasson

  This project tests whether a community-based screening program can find treatable eye problems in people aged 35 and older who live in Char Fasson, Bangladesh.

  Recruiting Data Yakka, Inc. · Char Fasson, Bhola · NCT07135570

• Vision screening in general practice to catch preventable sight loss in people over 70

  This project will test a GP-based vision-screening program for people aged 70 and older with at least one chronic condition to find sight problems early.

  Recruiting at 2 sites University of Copenhagen · Copenhagen, Capital Region and 1 other locations · NCT07015034

• Comparing two microinvasive glaucoma surgeries with cataract surgery

  This study tests which of two new glaucoma surgeries, MINIject or Hydrus, works better when done with cataract surgery for people with chronic glaucoma.

  Recruiting Medical University of Graz · Graz, Styria · NCT06844292

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.